Day: May 3, 2024

Article 223-16 of general regulation of French Autorité des Marchés Financiers Listing market: Euronext Paris (Market segment C – ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com Date Total of shares composing the share capital Total of brut (1) voting rights Total of net (2) voting rights December 31, 2023 6 075 105 6 226 982 6 226 733 January 31, 2024 6 075 105 6 227 002 6 226 753 February 29, 2024 6 075 105 6 226 951 6 226 702 March 29, 2024 6 075 105 6 226 938 6 226 689 April 30, 2024 6 075 105 6 226 932 6 226 683 (1)   Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying...

MANAGEMENT PRESENTATION TO BE WEBCAST LIVE AT 10:00 AM ET ON MAY 9, 2024 PRINCETON JUNCTION, N.J., May 03, 2024 (GLOBE NEWSWIRE) — MISTRAS Group, Inc. (MG: NYSE) – a leading “one source” multinational provider of technology-enabled asset protection solutions used to maximize the uptime and safety of critical energy, industrial, and public infrastructure – announced today that Manuel (Manny) Stamatakis, Chairman of the Board of Directors and Interim President and Chief Executive Officer, and Edward Prajzner, Senior Executive Vice President and Chief Financial Officer, will be speaking at the Sidoti Micro-Cap Virtual Investor Conference, being held May 8-9, 2024. The presentation will begin at 10:00 AM ET on Thursday, May 9, 2024. To register to attend and access the chat, please visit https://sidoti.zoom.us/webinar/register/WN_3uMLzI9USwmiGPq8IuVAQw#/registration. Management...

– Phase 3 BOND-003 study results showed sustained, durable complete responses over 12 months with novel investigational oncolytic immunotherapy – – Company will hold an investor conference call today at 4:30pm EDT – IRVINE, Calif., May 03, 2024 (GLOBE NEWSWIRE) — CG Oncology, Inc. today announced that data from the Phase 3 BOND-003 study evaluating the efficacy and safety of cretostimogene monotherapy in patients with high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) unresponsive to Bacillus Calmette Guerin (BCG), showed that 75.2% of patients (79 out of 105 [95% confidence interval (CI), 65-83]) achieved a complete response (CR) at any time, as of the cutoff date of April 1, 2024. These data were featured today at the Paradigm-Shifting, Practice-Changing Clinical Trials in Urology Plenary Session as...

3 May 2024 The EIB submits SEC Form 18-K The European Investment Bank (EIB) has submitted its SEC Form 18-K. To view the document, please go to: EDGAR Filing Documents for 0001104659-24-056727 (sec.gov). The 18-K has also been posted on the EIB website: EIB annual 18-K report 2023 ENDS

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF) Date of settlementof information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders’ meeting) April 30, 2024 20 455 403 714 864 22 375 860 21 660 996 March 31, 2024 20 455 403 696 391 22 376 742 21 680 351 February 29, 2024 20 455 403 700 847 22 376 636 21 675 789 January 31, 2024 20 455 403 697 328 22 376 636 21 679 308 December 31, 2023 20 455 403 701 329 22 376 736 21 675 407 (*) exclusively consisting of treasury shares.(**) theoretical voting rights to calculate the threshold...

Singapore, May 03, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading provider of AI-powered, digital-first education solutions, today announced the engagement of international investor relations specialists MZ Group (“MZ”) to lead a strategic investor relations and financial communications program across all key markets. MZ Group will work closely with Genius Group’s management to build upon their investor relations and shareholder communications program designed to increase the Company’s visibility throughout the investment community. The initiative will highlight Genius Group’s revolutionary approach that disrupts the traditional education pathways through the use of a personalized, flexible and life-long learning curriculum powered by artificial...

VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) — HIGHLIGHTS Significant exploration results delivered across Novo Resource’s (Novo or the Company) Western Australian gold portfolio, notably at the Becher and Nunyerry North Projects. Drill intercepts from the maiden Nunyerry North exploration program completed in H2 2023 were re-analysed by multi-pot PhotonAssayTM. This larger sample methodology has upgraded a number of the original significant intercepts1, with new intercepts including: 6 m @ 6.12 g/t Au from 37 m (NC017) 11 m @ 2.52 g/t Au from 22 m, including 6 m at 4.19 g/t Au from 22 m (NC014) 13 m @ 1.89 g/t Au from surface (NC004) 4 m @ 5.71 g/t Au from 40 m (NC015) 17 m @ 1.34 g/t Au from 37 m, including 4 m at 3.77 g/t Au from 50 m (NC022) 14 m at 1.14 g/t Au from 39 m, including 4 m at 2.16 g/t Au from...